Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Bruce A Woda MD

    TitleProfessor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentPathology
    AddressUniversity of Massachusetts Medical School
    1 Innovation Drive, Biotech Three
    Worcester MA 01655
    Phone508-793-6200
      Other Positions
      InstitutionUMMS - Graduate School of Biomedical Sciences
      DepartmentImmunology and Virology

        Overview 
        Narrative

        Academic Background

        • MD, 1975, SUNY Downstate
        • Resident in Anatomic Pathology - Columbia-Presbyterian Medical Center, New York, NY
        • Postdoctoral Fellow - Research Institute of Scripps Clinic, La Jolla, CA
        • Hematopathology Fellow - City of Hope National Medical Center, Duarte, CA

        Dr. Woda's pictureBruce Woda, M.D., Vice-Chairman, Department of Pathology and Chief, Anatomic Pathology: My research interests are focused in the biology of autoimmune diabetes, disorders of the hemopoietic system with a focus on histiocytic proliferative disorders, myelodysplastic syndromes and lymphoma. I am also interested in the identification of biomarkers for the clinical prediction of outcome in neoplasia. In conjunction with our Diabetes Endocrinology Research Center I am the Director of its Morphology Core Laboratory.



        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Usmani GN, Woda BA, Newburger PE. Advances in understanding the pathogenesis of HLH. Br J Haematol. 2013 Jun; 161(5):609-22.
          View in: PubMed
        2. Ramanathan M, Cerny J, Yu H, Woda BA, Nath R. A combination treatment approach and cord blood stem celltransplant for blastic plasmacytoid dendritic cell neoplasm. Haematologica. 2013 Jan 8.
          View in: PubMed
        3. Menon MP, Hutchinson L, Garver J, Jaffe ES, Woda BA. Transformation of follicular lymphoma to epstein-barr virus-related hodgkin-like lymphoma. J Clin Oncol. 2013 Feb 10; 31(5):e53-6.
          View in: PubMed
        4. Cerny J, Yu H, Ramanathan M, Raffel GD, Walsh WV, Fortier N, Shanahan L, O'Rourke E, Bednarik J, Barton B, Kroll-Desrosiers A, Hao S, Woda B, Hutchinson L, M Evens A, Rosmarin AG, Nath R. Expression of CD25 independently predicts early treatment failure of acute myeloid leukaemia (AML). Br J Haematol. 2012 Nov 1.
          View in: PubMed
        5. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012 Sep 14; 150(6):1135-46.
          View in: PubMed
        6. Gannon HS, Woda BA, Jones SN. ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice. Cancer Cell. 2012 May 25; 21(5):668-79.
          View in: PubMed
        7. Jagadeesh D, Woda BA, Draper J, Evens AM. Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations. Curr Treat Options Oncol. 2012 Mar; 13(1):122-36.
          View in: PubMed
        8. Young JL, Mora A, Cerny A, Czech MP, Woda B, Kurt-Jones EA, Finberg RW, Corvera S. CD14 Deficiency Impacts Glucose Homeostasis in Mice through Altered Adrenal Tone. PLoS One. 2012; 7(1):e29688.
          View in: PubMed
        9. Lu D, Yang X, Jiang NY, Woda BA, Liu Q, Dresser K, Mercurio AM, Rock KL, Jiang Z. IMP3, a New Biomarker to Predict Progression of Cervical Intraepithelial Neoplasia Into Invasive Cancer. Am J Surg Pathol. 2011 Nov; 35(11):1638-45.
          View in: PubMed
        10. Kurian EM, Caporelli ML, Baker S, Woda B, Cosar EF, Hutchinson L. Cervista HR and HPV 16/18 assays vs hybrid capture 2 assay: outcome comparison in women with negative cervical cytology. Am J Clin Pathol. 2011 Nov; 136(5):808-16.
          View in: PubMed
        11. Hao S, Smith TW, Chu PG, Liu Q, Ok CY, Woda BA, Lu D, Lin P, Wang SA, Dresser K, Rock KL, Jiang Z. The Oncofetal Protein IMP3: A Novel Molecular Marker to Predict Aggressive Meningioma. Arch Pathol Lab Med. 2011 Aug; 135(8):1032-6.
          View in: PubMed
        12. Shi M, Fraire AE, Chu P, Cornejo K, Woda BA, Dresser K, Rock KL, Jiang Z. Oncofetal Protein IMP3, a New Diagnostic Biomarker to Distinguish Malignant Mesothelioma From Reactive Mesothelial Proliferation. Am J Surg Pathol. 2011 Jun; 35(6):878-82.
          View in: PubMed
        13. Zhang L, Liu Y, Hao S, Woda BA, Lu D. IMP2 Expression Distinguishes Endometrioid From Serous Endometrial Adenocarcinomas. Am J Surg Pathol. 2011 Jun; 35(6):868-72.
          View in: PubMed
        14. Shi M, Minehart Miron P, Hutchinson L, Woda BA, Nath R, Cerny J, Yu H. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements. Hum Pathol. 2011 Oct; 42(10):1562-7.
          View in: PubMed
        15. Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res. 2011 Jun; 35(6):766-70.
          View in: PubMed
        16. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, Grant AV, Marchal CC, Hubeau M, Chapgier A, de Beaucoudrey L, Puel A, Feinberg J, Valinetz E, Jannière L, Besse C, Boland A, Brisseau JM, Blanche S, Lortholary O, Fieschi C, Emile JF, Boisson-Dupuis S, Al-Muhsen S, Woda B, Newburger PE, Condino-Neto A, Dinauer MC, Abel L, Casanova JL. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. 2011 Mar; 12(3):213-21.
          View in: PubMed
        17. Chang TY, Jaffray J, Woda B, Newburger PE, Usmani GN. Hemophagocytic lymphohistiocytosis with MUNC13-4 gene mutation or reduced natural killer cell function prior to onset of childhood leukemia. Pediatr Blood Cancer. 2011 May; 56(5):856-8.
          View in: PubMed
        18. Lisovsky M, Ogawa F, Dresser K, Woda B, Lauwers GY. Loss of cell polarity protein Lgl2 in foveolar-type gastric dysplasia: correlation with expression of the apical marker aPKC-zeta. Virchows Arch. 2010 Dec; 457(6):635-42.
          View in: PubMed
        19. Lisovsky M, Dresser K, Woda B, Mino-Kenudson M. Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias. Hum Pathol. 2010 Jun; 41(6):902-9.
          View in: PubMed
        20. Tirabassi RS, Guberski DL, Blankenhorn EP, Leif JH, Woda BA, Liu Z, Winans D, Greiner DL, Mordes JP. Infection with viruses from several families triggers autoimmune diabetes in LEW*1WR1 rats: prevention of diabetes by maternal immunization. Diabetes. 2010 Jan; 59(1):110-8.
          View in: PubMed
        21. Tang G, Woods LJ, Wang SA, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol. 2009 Aug; 40(8):1194-9.
          View in: PubMed
        22. Lisovsky M, Dresser K, Baker S, Fisher A, Woda B, Banner B, Lauwers GY. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study. Mod Pathol. 2009 Jul; 22(7):977-84.
          View in: PubMed
        23. Lu D, Vohra P, Chu PG, Woda B, Rock KL, Jiang Z. An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia. Am J Surg Pathol. 2009 Apr; 33(4):521-5.
          View in: PubMed
        24. Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang SA. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study. Leuk Res. 2009 Aug; 33(8):1039-46.
          View in: PubMed
        25. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer. 2008 Dec 15; 113(12):3331-40.
          View in: PubMed
        26. Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica. 2009 Jan; 94(1):29-37.
          View in: PubMed
        27. Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol. 2008 Nov; 21(11):1394-402.
          View in: PubMed
        28. Jiang Z, Chu PG, Woda BA, Liu Q, Balaji KC, Rock KL, Wu CL. Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Clin Cancer Res. 2008 Sep 1; 14(17):5579-84.
          View in: PubMed
        29. Giassi LJ, Pearson T, Shultz LD, Laning J, Biber K, Kraus M, Woda BA, Schmidt MR, Woodland RT, Rossini AA, Greiner DL. Expanded CD34+ human umbilical cord blood cells generate multiple lymphohematopoietic lineages in NOD-scid IL2rgamma(null) mice. Exp Biol Med (Maywood). 2008 Aug; 233(8):997-1012.
          View in: PubMed
        30. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2008 Jul; 17(7):1648-52.
          View in: PubMed
        31. Akalin A, Lu D, Woda B, Moss L, Fischer A. Rapid cell blocks improve accuracy of breast FNAs beyond that provided by conventional cell blocks regardless of immediate adequacy evaluation. Diagn Cytopathol. 2008 Jul; 36(7):523-9.
          View in: PubMed
        32. Jiang Z, Lohse CM, Chu PG, Wu CL, Woda BA, Rock KL, Kwon ED. Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Cancer. 2008 Jun 15; 112(12):2676-82.
          View in: PubMed
        33. Zota V, Miron PM, Woda BA, Raza A, Wang SA. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia. J Clin Oncol. 2008 Apr 20; 26(12):2040-1.
          View in: PubMed
        34. Sitnikova L, Mendese G, Liu Q, Woda BA, Lu D, Dresser K, Mohanty S, Rock KL, Jiang Z. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Clin Cancer Res. 2008 Mar 15; 14(6):1701-6.
          View in: PubMed
        35. Hochberg JC, Miron PM, Hay BN, Woda BA, Wang SA, Richert-Przygonska M, Aprikyan AA, Newburger PE. Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatr Blood Cancer. 2008 Mar; 50(3):630-2.
          View in: PubMed
        36. Woda BA. Hypersensitivity pneumonitis: an immunopathology review. Arch Pathol Lab Med. 2008 Feb; 132(2):204-5.
          View in: PubMed
        37. Rosenwald IB, Koifman L, Savas L, Chen JJ, Woda BA, Kadin ME. Expression of the translation initiation factors eIF-4E and eIF-2* is frequently increased in neoplastic cells of Hodgkin lymphoma. Hum Pathol. 2008 Jun; 39(6):910-6.
          View in: PubMed
        38. Tang G, Truong F, Fadare O, Woda B, Wang SA. Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts. Int J Clin Exp Pathol. 2008; 1(6):544-9.
          View in: PubMed
        39. King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL. A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. Clin Immunol. 2008 Mar; 126(3):303-14.
          View in: PubMed
        40. Li C, Zota V, Woda BA, Rock KL, Fraire AE, Jiang Z, Lu D, Xu B, Dresser K, Lutman CV, Fischer AH. Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations. Mod Pathol. 2007 Dec; 20(12):1263-8.
          View in: PubMed
        41. Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leuk Res. 2008 Apr; 32(4):553-8.
          View in: PubMed
        42. Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang SA. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls. Leuk Res. 2008 Feb; 32(2):215-24.
          View in: PubMed
        43. Wang SA, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion. Br J Haematol. 2007 Jul; 138(2):271-5.
          View in: PubMed
        44. Stachurski D, Miron PM, Al-Homsi S, Hutchinson L, Harris NL, Woda B, Wang SA. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24. Hum Pathol. 2007 Jun; 38(6):940-5.
          View in: PubMed
        45. Li C, Rock KL, Woda BA, Jiang Z, Fraire AE, Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression. Mod Pathol. 2007 Feb; 20(2):242-7.
          View in: PubMed
        46. Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J Clin Pathol. 2006 Nov; 126(5):789-97.
          View in: PubMed
        47. Vanguri VK, Woda BA, Jiang Z. Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies. Appl Immunohistochem Mol Morphol. 2006 Sep; 14(3):365-8.
          View in: PubMed
        48. Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, Liu Q, Zhao W, Mehdi M, Galili N, Woda B, Raza A. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia. 2006 Sep; 20(9):1641-4.
          View in: PubMed
        49. Jiang Z, Chu PG, Woda BA, Rock KL, Liu Q, Hsieh CC, Li C, Chen W, Duan HO, McDougal S, Wu CL. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol. 2006 Jul; 7(7):556-64.
          View in: PubMed
        50. Habermann TM, Weller EA, Morrison VA, Gascoyne RD, Cassileth PA, Cohn JB, Dakhil SR, Woda B, Fisher RI, Peterson BA, Horning SJ. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol. 2006 Jul 1; 24(19):3121-7.
          View in: PubMed
        51. Rezk S, Wheelock L, Fletcher JA, Oliveira AM, Keuker CP, Newburger PE, Xu B, Woda BA, Miron PM. Acute lymphocytic leukemia with eosinophilia and unusual karyotype. Leuk Lymphoma. 2006 Jun; 47(6):1176-9.
          View in: PubMed
        52. Galili NB, Mehdi M, Mumtaz M, Miron P, Woda B, Al-Homsi S, Westervelt P, Raza A. Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes? Future Oncol. 2006 Jun; 2(3):407-15.
          View in: PubMed
        53. Carswell BM, Woda BA, Wang X, Li C, Dresser K, Jiang Z. Detection of prostate cancer by alpha-methylacyl CoA racemase (P504S) in needle biopsy specimens previously reported as negative for malignancy. Histopathology. 2006 May; 48(6):668-73.
          View in: PubMed
        54. Ross RW, Halabi S, Ou SS, Rajeshkumar BR, Woda BA, Vogelzang NJ, Small EJ, Taplin ME, Kantoff PW. Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer--a Cancer and Leukemia Group B study. Clin Cancer Res. 2005 Nov 15; 11(22):8109-13.
          View in: PubMed
        55. Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL, Kislauskis EH, Tirabassi RS. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes. 2005 Sep; 54(9):2727-33.
          View in: PubMed
        56. Retter MW, Johnson JC, Peckham DW, Bannink JE, Bangur CS, Dresser K, Cai F, Foy TM, Fanger NA, Fanger GR, Woda B, Rock KL. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. Cancer Res. 2005 Jul 15; 65(14):6425-34.
          View in: PubMed
        57. Wallace J, Woda BA, Pihan G. Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn. 2005 Feb; 7(1):72-80.
          View in: PubMed
        58. Jiang Z, Li C, Fischer A, Dresser K, Woda BA. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol. 2005 Feb; 123(2):231-6.
          View in: PubMed
        59. Yantiss RK, Woda BA, Fanger GR, Kalos M, Whalen GF, Tada H, Andersen DK, Rock KL, Dresser K. KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am J Surg Pathol. 2005 Feb; 29(2):188-95.
          View in: PubMed
        60. Jiang Z, Woda BA. Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy. Adv Anat Pathol. 2004 Nov; 11(6):316-21.
          View in: PubMed
        61. Jiang Z, Wu CL, Woda BA, Iczkowski KA, Chu PG, Tretiakova MS, Young RH, Weiss LM, Blute RD, Brendler CB, Krausz T, Xu JC, Rock KL, Amin MB, Yang XJ. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004 Sep; 45(3):218-25.
          View in: PubMed
        62. Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, Young RH, Jiang Z. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004 Aug; 35(8):1008-13.
          View in: PubMed
        63. Jiang Z, Woda BA, Wu CL, Yang XJ. Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004 Aug; 122(2):275-89.
          View in: PubMed
        64. Jiang Z, Iczkowski KA, Woda BA, Tretiakova M, Yang XJ. P504S immunostaining boosts diagnostic resolution of "suspicious" foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004 Jan; 121(1):99-107.
          View in: PubMed
        65. Rosenwald IB, Wang S, Savas L, Woda B, Pullman J. Expression of translation initiation factor eIF-2alpha is increased in benign and malignant melanocytic and colonic epithelial neoplasms. Cancer. 2003 Sep 1; 98(5):1080-8.
          View in: PubMed
        66. Jiang Z, Fanger GR, Woda BA, Banner BF, Algate P, Dresser K, Xu J, Chu PG. Expression of alpha-methylacyl-CoA racemase (P504s) in various malignant neoplasms and normal tissues: astudy of 761 cases. Hum Pathol. 2003 Aug; 34(8):792-6.
          View in: PubMed
        67. Yang XJ, Laven B, Tretiakova M, Blute RD, Woda BA, Steinberg GD, Jiang Z. Detection of alpha-methylacyl-coenzyme A racemase in postradiation prostatic adenocarcinoma. Urology. 2003 Aug; 62(2):282-6.
          View in: PubMed
        68. Taplin ME, Rajeshkumar B, Halabi S, Werner CP, Woda BA, Picus J, Stadler W, Hayes DF, Kantoff PW, Vogelzang NJ, Small EJ. Androgen receptor mutations in androgen-independent prostate cancer: Cancer and Leukemia Group B Study 9663. J Clin Oncol. 2003 Jul 15; 21(14):2673-8.
          View in: PubMed
        69. Wallace J, Zhou Y, Usmani GN, Reardon M, Newburger P, Woda B, Pihan G. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays. Leukemia. 2003 Jul; 17(7):1404-10.
          View in: PubMed
        70. Wallace J, Zhou Y, Usmani GN, Reardon M, Newburger P, Woda B, Pihan G. BARCODE-ALL: accelerated and cost-effective genetic risk stratification in acute leukemia using spectrally addressable liquid bead microarrays. Leukemia. 2003 Jul; 17(7):1411-3.
          View in: PubMed
        71. Jiang Z, Fanger GR, Banner BF, Woda BA, Algate P, Dresser K, Xu J, Reed SG, Rock KL, Chu PG. A dietary enzyme: alpha-methylacyl-CoA racemase/P504S is overexpressed in colon carcinoma. Cancer Detect Prev. 2003; 27(6):422-6.
          View in: PubMed
        72. Fraire AE, Woda BA, Savas L, Jiang Z. Intercellular adhesion molecules (ICAM-1, VCAM-1, and LFA-1) in adenocarcinoma of lung. Technical aspects. Methods Mol Med. 2003; 74:243-9.
          View in: PubMed
        73. Jiang Z, Wu CL, Woda BA, Dresser K, Xu J, Fanger GR, Yang XJ. P504S/alpha-methylacyl-CoA racemase: a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002 Sep; 26(9):1169-74.
          View in: PubMed
        74. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002 Jul; 26(7):921-5.
          View in: PubMed
        75. Jiang Z, Woda BA, Yang XJ. Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer. JAMA. 2002 Jun 19; 287(23):3080-1; author reply 3081.
          View in: PubMed
        76. Forman D, Welsh RM, Markees TG, Woda BA, Mordes JP, Rossini AA, Greiner DL. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms. J Immunol. 2002 Jun 15; 168(12):6047-56.
          View in: PubMed
        77. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001 Nov; 25(11):1397-404.
          View in: PubMed
        78. Liang SX, Lakshmanan Y, Woda BA, Jiang Z. A high-grade primary leiomyosarcoma of the bladder in a survivor of retinoblastoma. Arch Pathol Lab Med. 2001 Sep; 125(9):1231-4.
          View in: PubMed
        79. Moore BE, Banner BF, Gokden M, Woda B, Liu Y, Ayala A, Jiang Z. p53: a good diagnostic marker for intratubular germ cell neoplasia, unclassified. Appl Immunohistochem Mol Morphol. 2001 Sep; 9(3):203-6.
          View in: PubMed
        80. Gordon EJ, Woda BA, Shultz LD, Rossini AA, Greiner DL, Mordes JP. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells. Transplantation. 2001 Jan 27; 71(2):319-27.
          View in: PubMed
        81. Rosenwald IB, Pechet L, Han A, Lu L, Pihan G, Woda B, Chen JJ, Szymanski I. Expression of translation initiation factors elF-4E and elF-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost. 2001 Jan; 85(1):142-51.
          View in: PubMed
        82. Wagar EJ, Cromwell MA, Shultz LD, Woda BA, Sullivan JL, Hesselton RM, Greiner DL. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice. J Immunol. 2000 Jul 1; 165(1):518-27.
          View in: PubMed
        83. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA, Greiner DL. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood. 2000 Mar 15; 95(6):2175-82.
          View in: PubMed
        84. Welsh RM, Markees TG, Woda BA, Daniels KA, Brehm MA, Mordes JP, Greiner DL, Rossini AA. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody. J Virol. 2000 Mar; 74(5):2210-8.
          View in: PubMed
        85. Cai YC, Jiang Z, Vittimberga F, Xu X, Savas L, Woda B, Callery M, Banner B. Expression of transforming growth factor-alpha and epidermal growth factor receptor in gastrointestinal stromal tumours. Virchows Arch. 1999 Aug; 435(2):112-5.
          View in: PubMed
        86. Wang S, Rosenwald IB, Hutzler MJ, Pihan GA, Savas L, Chen JJ, Woda BA. Expression of the eukaryotic translation initiation factors 4E and 2alpha in non-Hodgkin's lymphomas. Am J Pathol. 1999 Jul; 155(1):247-55.
          View in: PubMed
        87. Markees TG, Serreze DV, Phillips NE, Sorli CH, Gordon EJ, Shultz LD, Noelle RJ, Woda BA, Greiner DL, Mordes JP, Rossini AA. NOD mice have a generalized defect in their response to transplantation tolerance induction. Diabetes. 1999 May; 48(5):967-74.
          View in: PubMed
        88. Jiang Z, Woda BA, Savas L, Fraire AE. Expression of ICAM-1, VCAM-1, and LFA-1 in adenocarcinoma of the lung with observations on the expression of these adhesion molecules in non-neoplastic lung tissue. Mod Pathol. 1998 Dec; 11(12):1189-92.
          View in: PubMed
        89. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998 Sep 1; 58(17):3974-85.
          View in: PubMed
        90. Dubin DB, Hurowitz JC, Brettler D, Bernhard JD, Kadin ME, Wallace JE, Woda B, Pihan G, Kupper TS, Harrist TJ. Adnexotropic T-cell lymphoma presenting with generalized anhidrosis, progressive alopecia, pruritus, and Sjögren's syndrome. J Am Acad Dermatol. 1998 Mar; 38(3):493-7.
          View in: PubMed
        91. Cai YC, Barnard G, Hiestand L, Woda B, Colby J, Banner B. Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am J Surg Pathol. 1997 Nov; 21(11):1373-7.
          View in: PubMed
        92. Kershaw GR, Berger C, McQuain C, al-Homsi AS, Pihan G, Quesenberry PJ, Woda BA, Knecht H. Selective outgrowth of a posttransplant B-immunoblastic lymphoma expressing a latent membrane protein-1 deletion variant. Transplantation. 1997 Oct 15; 64(7):1079-81.
          View in: PubMed
        93. Banner B, Beauchamp ML, Liepman M, Woda BA. Interdigitating reticulum-cell sarcoma of the intestine: a case report and review of the literature. Diagn Cytopathol. 1997 Sep; 17(3):216-22.
          View in: PubMed
        94. Rho R, Laddis T, McQuain C, Selves J, Woda B, Knecht H. Miliary tuberculosis in a patient with Epstein-Barr virus-associated angioimmunoblastic lymphadenopathy. Ann Hematol. 1996 May; 72(5):333-5.
          View in: PubMed
        95. Rao SK, Krishna M, Woda BA, Savas L, Fraire AE. Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung. Mod Pathol. 1996 May; 9(5):555-9.
          View in: PubMed
        96. Knecht H, Raphaël M, McQuain C, Rothenberger S, Pihan G, Camilleri-Broët S, Bachmann E, Kershaw GR, Ryan S, Kittler EL, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood. 1996 Feb 1; 87(3):876-81.
          View in: PubMed
        97. Krishna M, Woda B, Savas L, Baker S, Banner B. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod Pathol. 1995 Aug; 8(6):654-7.
          View in: PubMed
        98. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr, and Bcl-2-transgenic mice. Am J Pathol. 1995 Jul; 147(1):79-91.
          View in: PubMed
        99. Banner BF, Savas L, Woda BA. Expression of adhesion molecules in the host response to colon carcinoma. Ultrastruct Pathol. 1995 Mar-Apr; 19(2):113-8.
          View in: PubMed
        100. Kerschmann RL, Woda BA, Majno G. The fusion of tumor cells with host cells; reflections on an ovarian tumor. Perspect Biol Med. 1995; 38(3):467-75.
          View in: PubMed
        101. Potocki L, Townes PL, Woda BA, Rao SK, Shearin JP, Schwenn MR. Tetrasomy 21 in megakaryoblastic leukemia. Cancer Genet Cytogenet. 1994 May; 74(1):66-70.
          View in: PubMed
        102. Szomolanyi-Tsuda E, Dundon PL, Joris I, Shultz LD, Woda BA, Welsh RM. Acute, lethal, natural killer cell-resistant myeloproliferative disease induced by polyomavirus in severe combined immunodeficient mice. Am J Pathol. 1994 Feb; 144(2):359-71.
          View in: PubMed
        103. Jiang Z, Makowiecki J, Mordes JP, Woda BA. Cytolysin gene expression in the islets of diabetic BioBreeding/Worcester rats. J Immunol. 1994 Jan 1; 152(1):322-9.
          View in: PubMed
        104. Woda BA, Sullivan JL. Reactive histiocytic disorders. Am J Clin Pathol. 1993 Apr; 99(4):459-63.
          View in: PubMed
        105. Maher VE, Gill L, Townes PL, Wallace JE, Savas L, Woda BA, Ansell JE. Simultaneous chronic lymphocytic leukemia and chronic myelogenous leukemia. Evidence of a separate stem cell origin. Cancer. 1993 Mar 15; 71(6):1993-7.
          View in: PubMed
        106. Takagi S, McFadden ML, Humphreys RE, Woda BA, Sairenji T. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Cytometry. 1993; 14(6):640-8.
          View in: PubMed
        107. Banner BF, Savas L, Baker S, Woda BA. Characterization of the inflammatory cell populations in normal colon and colonic carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993; 64(4):213-20.
          View in: PubMed
        108. Knorr JR, Ragland RL, Stone BB, Woda BA, Gelber ND. Cerebellar T-cell lymphoma: an unusual primary intracranial neoplasm. Neuroradiology. 1992; 35(1):79-81.
          View in: PubMed
        109. Jiang Z, Woda BA. Cytokine gene expression in the islets of the diabetic Biobreeding/Worcester rat. J Immunol. 1991 May 1; 146(9):2990-4.
          View in: PubMed
        110. Woda BA, Handler ES, Greiner DL, Reynolds C, Mordes JP, Rossini AA. T-lymphocyte requirement for diabetes in RT6-depleted diabetes-resistant BB rats. Diabetes. 1991 Apr; 40(4):423-8.
          View in: PubMed
        111. Thomas VA, Woda BA, Handler ES, Greiner DL, Mordes JP, Rossini AA. Altered expression of diabetes in BB/Wor rats by exposure to viral pathogens. Diabetes. 1991 Feb; 40(2):255-8.
          View in: PubMed
        112. Malatskey A, Reuter KL, Woda B. Sonographic findings in primary uterine cervical lymphoma. J Clin Ultrasound. 1991 Jan; 19(1):62-4.
          View in: PubMed
        113. Jiang Z, Handler ES, Rossini AA, Woda BA. Immunopathology of diabetes in the RT6-depleted diabetes-resistant BB/Wor rat. Am J Pathol. 1990 Oct; 137(4):767-77.
          View in: PubMed
        114. Strongwater SL, Woda BA, Yood RA, Rybak ME, Sargent J, DeGirolami U, Smith TW, Varnis C, Allen S, Murphy K, et al. Eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Analysis of four patients and implications for differential diagnosis and pathogenesis. Arch Intern Med. 1990 Oct; 150(10):2178-86.
          View in: PubMed
        115. Nakamura N, Woda BA, Tafuri A, Greiner DL, Reynolds CW, Ortaldo J, Chick W, Handler ES, Mordes JP, Rossini AA. Intrinsic cytotoxicity of natural killer cells to pancreatic islets in vitro. Diabetes. 1990 Jul; 39(7):836-43.
          View in: PubMed
        116. Santucci MA, FitzGerald TJ, Harigaya K, Woda B, Sakakeeny MA, Anklesaria P, Kase K, Holland CA, Greenberger JS. Gamma-irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity. Int J Radiat Oncol Biol Phys. 1990 May; 18(5):1083-92.
          View in: PubMed
        117. Pihan GA, Woda BA. Immunophenotypic analysis of cells isolated from bone marrow biopsies in patients with failed bone marrow aspiration ('dry tap'). Am J Clin Pathol. 1990 Apr; 93(4):545-8.
          View in: PubMed
        118. Boruchoff SE, Woda BA, Pihan GA, Durbin WA, Burstein D, Blacklow NR. Parvovirus B19-associated hemophagocytic syndrome. Arch Intern Med. 1990 Apr; 150(4):897-9.
          View in: PubMed
        119. Fram RJ, Woda BA, Wilson JM, Robichaud N. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells. Cancer Res. 1990 Jan 1; 50(1):72-7.
          View in: PubMed
        120. Sullivan JL, Woda BA. X-linked lymphoproliferative syndrome. Immunodefic Rev. 1989; 1(4):325-47.
          View in: PubMed
        121. FitzGerald TJ, Santucci MA, Harigaya K, Woda B, McKenna M, Sakakeeny MA, Pierce JH, Kase K, Holland CA, Greenberger JS. Radiosensitivity of permanent human bone marrow stromal cell lines: effect of dose rate. Int J Radiat Oncol Biol Phys. 1988 Nov; 15(5):1153-9.
          View in: PubMed
        122. Waite RJ, Doherty PW, Liepman M, Woda B. Langerhans cell histiocytosis with the radiographic findings of Erdheim-Chester disease. AJR Am J Roentgenol. 1988 Apr; 150(4):869-71.
          View in: PubMed
        123. Gupta SK, Woda BA. Ligand-induced association of surface immunoglobulin with the detergent insoluble cytoskeleton may involve alpha-actinin. J Immunol. 1988 Jan 1; 140(1):176-82.
          View in: PubMed
        124. Daum GS, Sullivan JL, Ansell J, Mulder C, Woda BA. Virus-associated hemophagocytic syndrome: identification of an immunoproliferative precursor lesion. Hum Pathol. 1987 Oct; 18(10):1071-4.
          View in: PubMed
        125. Woda BA, Padden C. BioBreeding/Worcester (BB/Wor) rats are deficient in the generation of functional cytotoxic T cells. J Immunol. 1987 Sep 1; 139(5):1514-7.
          View in: PubMed
        126. Ansell J, Badon S, Woda BA, Smith TW. Diabetes insipidus associated with dysplastic pancytopenia. Am J Med. 1987 Jul; 83(1):189.
          View in: PubMed
        127. Sairenji T, Nguyen QV, Woda B, Humphreys RE. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen. J Immunol. 1987 Apr 15; 138(8):2645-52.
          View in: PubMed
        128. Morad N, Strongwater SL, Eypper S, Woda BA. Idiopathic retroperitoneal and mediastinal fibrosis mimicking connective tissue disease. Am J Med. 1987 Feb; 82(2):363-6.
          View in: PubMed
        129. Sairenji T, Nguyen QV, Woda B, Humphreys RE. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines. AIDS Res. 1986 Dec; 2 Suppl 1:S57-60.
          View in: PubMed
        130. Kadin ME, Sako D, Berliner N, Franklin W, Woda B, Borowitz M, Ireland K, Schweid A, Herzog P, Lange B, et al. Childhood Ki-1 lymphoma presenting with skin lesions and peripheral lymphadenopathy. Blood. 1986 Nov; 68(5):1042-9.
          View in: PubMed
        131. Woda BA, Biron CA. Natural killer cell number and function in the spontaneously diabetic BB/W rat. J Immunol. 1986 Sep 15; 137(6):1860-6.
          View in: PubMed
        132. Naparstek E, FitzGerald TJ, Sakakeeny MA, Klassen V, Pierce JH, Woda BA, Falco J, Fitzgerald S, Nizin P, Greenberger JS. Induction of malignant transformation of cocultivated hematopoietic stem cells by X-irradiation of murine bone marrow stromal cells in vitro. Cancer Res. 1986 Sep; 46(9):4677-84.
          View in: PubMed
        133. Woda BA, Padden C. Mitogen responsiveness of lymphocytes from the BB/W rat. Diabetes. 1986 May; 35(5):513-6.
          View in: PubMed
        134. Woda BA, Like AA, Padden C, McFadden ML. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat. J Immunol. 1986 Feb 1; 136(3):856-9.
          View in: PubMed
        135. Forman SJ, Nathwani BN, Woda BA, Paladugu RR, Farbstein MJ. Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. A morphologic and immunologic study. Arch Pathol Lab Med. 1985 Dec; 109(12):1081-4.
          View in: PubMed
        136. Daum GS, Liepman M, Woda BA. Dendritic cell phenotype in localized malignant histiocytosis of the small intestine. Arch Pathol Lab Med. 1985 Jul; 109(7):647-50.
          View in: PubMed
        137. Tracy SE, Woda BA, Robinson HL. Induction of angiosarcoma by a c-erbB transducing virus. J Virol. 1985 May; 54(2):304-10.
          View in: PubMed
        138. Sullivan JL, Woda BA, Herrod HG, Koh G, Rivara FP, Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood. 1985 May; 65(5):1097-104.
          View in: PubMed
        139. Badon SJ, Ansell J, Smith TW, Coslovsky R, Gill L, Woda BA. Diabetes insipidus caused by extramedullary hematopoiesis. Am J Clin Pathol. 1985 Apr; 83(4):509-12.
          View in: PubMed
        140. Woda BA, Woodin MB. The interaction of lymphocyte membrane proteins with the lymphocyte cytoskeletal matrix. J Immunol. 1984 Nov; 133(5):2767-72.
          View in: PubMed
        141. Bukowski JF, Woda BA, Welsh RM. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol. 1984 Oct; 52(1):119-28.
          View in: PubMed
        142. Ryan PJ, Davis MA, DeGaeta LR, Woda B, Melchior DL. Liposomes loaded with contrast material for image enhancement in computed tomography. Work in progress. Radiology. 1984 Sep; 152(3):759-62.
          View in: PubMed
        143. Rossini AA, Faustman D, Woda BA, Like AA, Szymanski I, Mordes JP. Lymphocyte transfusions prevent diabetes in the Bio-Breeding/Worcester rat. J Clin Invest. 1984 Jul; 74(1):39-46.
          View in: PubMed
        144. Rossini AA, Slavin S, Woda BA, Geisberg M, Like AA, Mordes JP. Total lymphoid irradiation prevents diabetes mellitus in the Bio-Breeding/Worcester (BB/W) rat. Diabetes. 1984 Jun; 33(6):543-7.
          View in: PubMed
        145. Woda BA, McFadden ML, Welsh RM, Bain KM. Separation and isolation of rat natural killer (NK) cells from T cells with monoclonal antibodies. J Immunol. 1984 May; 132(5):2183-4.
          View in: PubMed
        146. Woda BA, Bain K, Vander Salm T. The phenotype of lymphocytes in a thymoma as studied with monoclonal antibodies. Clin Immunol Immunopathol. 1984 Feb; 30(2):197-201.
          View in: PubMed
        147. Woda BA, McFadden ML. Ligand-induced association of rat lymphocyte membrane proteins with the detergent-insoluble lymphocyte cytoskeletal matrix. J Immunol. 1983 Oct; 131(4):1917-9.
          View in: PubMed
        148. Bukowski JF, Woda BA, Habu S, Okumura K, Welsh RM. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J Immunol. 1983 Sep; 131(3):1531-8.
          View in: PubMed
        149. Woda BA, Gilman SC. Lateral mobility and capping of rat lymphocyte membrane proteins. Cell Biol Int Rep. 1983 Mar; 7(3):203-9.
          View in: PubMed
        150. Woda BA, McFadden ML. Ligand-induced capping of surface proteins on trifluoperazine-treated macrophages. Exp Cell Res. 1982 Aug; 140(2):447-53.
          View in: PubMed
        151. Woda BA, Yguerabide J, Feldman JD. Mobility of surface proteins on normal rat macrophages and on a "macrophagelike" rat tumor. J Cell Biol. 1981 Sep; 90(3):705-10.
          View in: PubMed
        152. Gilman SC, Woda BA, Feldman JD. T lymphocytes of young and aged rats. I. Distribution, density, and capping of T antigens. J Immunol. 1981 Jul; 127(1):149-53.
          View in: PubMed
        153. Woda BA, Racklin B, Rappaport H. Altered expression of histocompatibility antigens on "B" large cell lymphomas. Blood. 1981 Apr; 57(4):802-4.
          View in: PubMed
        154. Godman G, Woda B, Kolberg R, Berl S. Redistribution of contractile and cytoskeletal components induced by cytochalasin. II. In HeLa and HEp2 cells. Eur J Cell Biol. 1980 Oct; 22(2):745-54.
          View in: PubMed
        155. Fernandez-Cruz E, Woda BA, Feldman JD. Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. J Exp Med. 1980 Oct 1; 152(4):823-41.
          View in: PubMed
        156. Godman G, Woda B, Kolberg R, Berl S. Redistribution of contractile and cytoskeletal components induced by cytochalasin. I. In Hmf cells, a nontransformed fibroblastoid line. Eur J Cell Biol. 1980 Oct; 22(2):733-44.
          View in: PubMed
        157. Woda BA, Balint JP, Feldman JD. Recognition of immune complexes and antigen in vivo. J Immunol. 1980 Sep; 125(3):1011-6.
          View in: PubMed
        158. Woda BA, Yguerabide J, Feldman JD. The effect of local anesthetics on the lateral mobility of lymphocyte membrane proteins. Exp Cell Res. 1980 Apr; 126(2):327-31.
          View in: PubMed
        159. Feldman JD, Woda BA. Pathology and tumor incidence in aged Lewis and BN rats. Clin Immunol Immunopathol. 1980 Mar; 15(3):331-43.
          View in: PubMed
        160. Woda BA, Yguerabide J, Feldman JD. Mobility and density of AgB, "Ia", and Fc receptors on the surface of lymphocytes from young and old rats. J Immunol. 1979 Nov; 123(5):2161-7.
          View in: PubMed
        161. Woda BA, Feldman JD. Density of surface immunoglobulin and capping on rat B lymphocytes. I. Changes with aging. J Exp Med. 1979 Feb 1; 149(2):416-23.
          View in: PubMed
        162. Woda BA, Knowles DM. Nodular lymphocytic lymphoma eventuating into diffuse histiocytic lymphoma: immunoperoxidase demonstration of monoclonality. Cancer. 1979 Jan; 43(1):303-7.
          View in: PubMed
        163. Appel GB, Woda BA, Neu HC, Parry MF, Silva F, Pirani CL. Acute interstitial nephritis associated with carbenicillin therapy. Arch Intern Med. 1978 Aug; 138(8):1265-7.
          View in: PubMed
        164. Woda BA, Forde K, Lane N. A unicryptal colonic adenoma, the smallest colonic neoplasm yet observed in a non-polyposis individual. Am J Clin Pathol. 1977 Nov; 68(5):631-2.
          View in: PubMed
        165. Woda BA, Fenoglio CM, Nette EG, King DW. The lack of specificity of the sheep erythrocyte-T lymphocyte rosetting phenomenon. Am J Pathol. 1977 Jul; 88(1):69-80.
          View in: PubMed
        166. Woda BA. Immune complexes in rheumatic disease. Lancet. 1976 Oct 16; 2(7990):859.
          View in: PubMed
        167. Pertschuk LP, Woda BA, Vuletin JC, Brigati DJ, Soriano CB, Nicastri AD. Glomerulonephritis due to Staphylococcus aureus antigen. Am J Clin Pathol. 1976 Mar; 65(3):301-7.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Bruce's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572